A Quality Improvement Initiative to Improve the Administration of Systemic Corticosteroids in the Pediatric Emergency

Hannah Sneller1,2, Kaitlin Keenan3, Eric Hoppa4,5

  • 1Division of Emergency Medicine, Children's Hospital and Medical Center, Omaha, Neb.

Insights

This quality improvement project successfully reduced the time to administer corticosteroids for pediatric asthma exacerbations in the emergency department (ED). The interventions improved timely steroid delivery and sustained these positive outcomes for 18 months.

Area of Science:

  • Pediatric Emergency Medicine
  • Quality Improvement Science
  • Asthma Management

Background:

  • Timely corticosteroid administration is crucial for effective pediatric asthma care in emergency departments (EDs).
  • Acute asthma exacerbations in children require prompt treatment to improve outcomes.

Purpose of the Study:

  • To decrease the time to corticosteroid delivery for pediatric patients with acute asthma exacerbations in the ED.
  • To implement and sustain improvements in asthma care protocols using a Model for Improvement.

Main Methods:

  • A single-center, prospective, multidisciplinary quality improvement (QI) project targeted pediatric ED patients (1-18 years) with acute asthma exacerbations.
  • Interventions included staff reeducation, electronic health record modifications, and real-time feedback over 9 months.
  • Data were collected for 5 months at baseline and 15 months post-intervention.

Main Results:

  • The percentage of patients receiving steroids within 60 minutes improved from 59.3% to 84.3%.
  • Mean time to steroid administration decreased from 71.4 to 48.1 minutes.
  • No increase in ED return rates was observed.

Conclusions:

  • The QI project significantly improved the timely administration of corticosteroids for pediatric asthma exacerbations in the ED.
  • Sustained improvements in steroid delivery time were achieved for 18 months post-intervention.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
619
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
154
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
330
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.6K